ArticleCell death discovery2021

miR-5000-3p confers oxaliplatin resistance by targeting ubiquitin-specific peptidase 49 in colorectal cancer.

Yan-Yan Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.